Jeffrey Goldberg
Geen lopende functies
Oorsprong van het eerstegraads netwerk van Jeffrey Goldberg
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 23 | |
| Extinct | Biotechnology | 5 | |
| Public Company | Biotechnology | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Jeffrey Goldberg via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Corporate Officer/Principal | |
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Director of Finance/CFO Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor Human Resources Officer Chief Tech/Sci/R&D Officer | |
| IONIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Corporate Officer/Principal Director/Board Member Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| MERCK KGAA | Pharmaceuticals: Major | Compliance Officer | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member Director/Board Member | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| CYTOKINETICS, INCORPORATED | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| RADIUS HEALTH, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| ATYR PHARMA, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| AVIDITY BIOSCIENCES, INC. | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
| University of Pennsylvania | College/University | Undergraduate Degree | |
| MODERNA, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Compliance Officer Corporate Officer/Principal | |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer President | |
| Yale University | College/University | Undergraduate Degree Doctorate Degree | |
| LOGICBIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| REGULUS THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Franklin & Marshall College | College/University | Undergraduate Degree Undergraduate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| San Diego State University | College/University | Corporate Officer/Principal Undergraduate Degree | |
| University of Vermont | College/University | Corporate Officer/Principal | |
| University of California San Diego | College/University | Corporate Officer/Principal | |
| CHECKMATE PHARMACEUTICALS, INC. | Biotechnology | Director of Finance/CFO | |
| AUTOLUS THERAPEUTICS PLC | Biotechnology | Director of Finance/CFO | |
| UNIQURE N.V. | Biotechnology | Director/Board Member | |
| DIANTHUS THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| ALKERMES PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Tufts University | College/University | Graduate Degree | |
| Royal Institute of Technology | College/University | Doctorate Degree | |
Rallybio LLC
 Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Miscellaneous Commercial Services | Director/Board Member | |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The private company is based in Wilmington, DE. | Pharmaceuticals: Major | Director/Board Member | |
| RALLYBIO CORPORATION | Biotechnology | Director/Board Member | |
Dianthus Therapeutics, Inc. (Massachusetts)
 Dianthus Therapeutics, Inc. (Massachusetts) BiotechnologyHealth Technology Dianthus Therapeutics OpCo, Inc. provides heath care services. The company was founded by Jonathan Violin and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member | |
| Columbus School of Law | College/University | Graduate Degree | |
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Investment Managers | Consultant / Advisor | |
Ensoma, Inc.
 Ensoma, Inc. Miscellaneous Commercial ServicesCommercial Services Ensoma, Inc. believes in the future of medicine and is committed to creating a new therapeutic category to tackle diseases that affect millions around the world, such as cancer and autoimmune disease, as well as inherited conditions. Ensoma is based in Boston, MA and has subsidiaries in Denmark. The company's engenious™ platform combines innovative delivery technology with the full DNA editing toolkit to address these disorders. Ensoma is supported by top-tier investors, a strategic collaboration with Takeda, and a passionate team. The company was founded by André Lieber, Hans-Peter Kiem, Kush M. Parmar, and the CEO is Emile F. Nuwaysir. | Miscellaneous Commercial Services | Chairman | |
| AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Boston College | College/University | Undergraduate Degree | |
Fortel Invest Oy
 Fortel Invest Oy Investment ManagersFinance Fortel Invest Oy (Fortel Invest) is a private equity subsidiary of Sipila Family founded in 1995 by Juha Sipila. The firm is headquartered in Oulu, Finland. | Investment Managers | Director of Finance/CFO | |
| University College Dublin | College/University | Doctorate Degree | |
| Serono Corp. | Corporate Officer/Principal |
Statistieken
Internationaal
| Verenigde Staten | 40 |
| Verenigd Koninkrijk | 3 |
| Ierland | 3 |
| Duitsland | 2 |
| Nederland | 2 |
Sectoraal
| Health Technology | 30 |
| Consumer Services | 13 |
| Commercial Services | 5 |
| Finance | 3 |
Operationeel
| Director/Board Member | 111 |
| Corporate Officer/Principal | 68 |
| Independent Dir/Board Member | 29 |
| Undergraduate Degree | 28 |
| Chief Tech/Sci/R&D Officer | 28 |
Sterkste connecties
| Insiders | |
|---|---|
| Joseph Klein | 24 |
| Christopher F. O. Gabrieli | 21 |
| Bernard Davitian | 19 |
| Sandy Smith | 19 |
| B. Parshall | 17 |
| Mark Enyedy | 15 |
| Stanley Crooke | 14 |
| David Weiner | 14 |
| Paula Soteropoulos | 13 |
| Richard A. Moscicki | 13 |
| Michael Yang | 11 |
| Michael MacLean | 11 |
| Sarah Boyce | 11 |
| Linda Neuman | 9 |
| Elaine Hochberg | 9 |
- Beurs
- Insiders
- Jeffrey Goldberg
- Bedrijfsconnecties
